Key facts for DRG 850
- FY2027 relative weight
- 8.4113
- Higher than 98% of all MS-DRGs
- Change vs FY2026
- -2.9%
- FY2026 weight 8.6595
- Geometric mean LOS
- 15.6 days
- Arithmetic mean 23.2 days
- MDC
- 17
- Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms
- Severity level
- single severity level
- National unadjusted operating payment
- $57,600.58
- Weight × $6,848.00 FY2027 standardized amount; capital adds $4,541.68
- Transfer policy
- Not a transfer DRG
TL;DR
MS-DRG 850 is a surgical group in MDC 17 (Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms), with no CC/MCC severity split. CMS assigns it a FY2027 relative weight of 8.4113 with a geometric mean length of stay of 15.6 days and an arithmetic mean of 23.2. Its weight moved down 2.9% from FY2026 (8.6595). That weight is higher than 98% of all MS-DRGs. The v44 Definitions Manual assigns it through 33 principal diagnosis codes and 189 non-operating room procedures codes.
What changed from FY2026 to FY2027
CMS recalibrates every MS-DRG weight annually from the prior year's MedPAR claims. For DRG 850 the FY2027 relative weight is 8.4113 against 8.6595 in FY2026, a fall of 2.87%, which exceeds the 2% threshold worth re-checking in contract models.
| Metric | FY2026 | FY2027 | Change |
|---|---|---|---|
| Relative weight | 8.6595 | 8.4113 | -0.2482 |
| Geometric mean LOS (days) | 15.3 | 15.6 | +0.3 |
| Arithmetic mean LOS (days) | 23.0 | 23.2 | +0.2 |
CC and MCC family
DRG 850 stands alone: CMS does not split this base group by CC or MCC severity, so complication documentation does not move the assignment, although it still affects quality and risk-adjustment reporting.
National unadjusted payment for DRG 850
Multiplying the FY2027 relative weight (8.4113) by the national rates in IPPS Tables 1A and 1D, as corrected by notice CMS-1849-CN3, gives the base amounts below. This group has no CC/MCC sibling, so the amount does not change with secondary-diagnosis capture.
| Component | National rate | DRG 850 |
|---|---|---|
| Operating (labor and nonlabor share) | $4,519.68 + $2,328.32 = $6,848.00 | $57,600.58 |
| Capital (federal rate) | $539.95 | $4,541.68 |
| Operating plus capital | $62,142.26 |
These are national, unadjusted figures, not what a given hospital is paid. The labor share is multiplied by the hospital's wage index (Table 1A applies when the wage index is above 1.0 and Table 1B otherwise), and teaching (IME), disproportionate share (DSH), outlier, transfer and new-technology add-on rules then change the amount for each stay. Use the figures to compare groups and to size a documentation finding, not to forecast a remittance; the DRG payment calculator applies a hospital's own wage index and teaching and DSH factors to DRG 850.
Risk-adjusting diagnoses in this DRG
Appendix B of the v44 Definitions Manual lists 33 ICD-10-CM codes in the logic for DRG 850; 33 of them also map to a CMS-HCC V28 payment category, across 3 categories. The same documentation that supports the inpatient group feeds Medicare Advantage risk adjustment when the patient is an MA enrollee.
| V28 HCC | Category | Shared codes | Examples |
|---|---|---|---|
| HCC 17 | Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic | 24 | C92.00, C92.01, C92.02 |
| HCC 18 | Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid | 6 | C91.00, C91.01, C91.02 |
| HCC 22 | Bladder, Colorectal, and Other Cancers | 3 | C92.40, C92.41, C92.42 |
Grouper logic (v44 Definitions Manual)
Criteria stated in the manual
- Any other operating room procedure not listed in DRGs 820-822
- Any of the following non-operating room procedures
Principal Diagnosis: 33 ICD-10-CM codes in this DRG's assignment logic; the first 12 are shown.
| ICD-10-CM code | Description |
|---|---|
| C91.00 | Acute lymphoblastic leukemia not having achieved remission |
| C91.01 | Acute lymphoblastic leukemia, in remission |
| C91.02 | Acute lymphoblastic leukemia, in relapse |
| C92.00 | Acute myeloblastic leukemia, not having achieved remission |
| C92.01 | Acute myeloblastic leukemia, in remission |
| C92.02 | Acute myeloblastic leukemia, in relapse |
| C92.40 | Acute promyelocytic leukemia, not having achieved remission |
| C92.41 | Acute promyelocytic leukemia, in remission |
| C92.42 | Acute promyelocytic leukemia, in relapse |
| C92.50 | Acute myelomonocytic leukemia, not having achieved remission |
| C92.51 | Acute myelomonocytic leukemia, in remission |
| C92.52 | Acute myelomonocytic leukemia, in relapse |
Non-Operating Room Procedures: 189 ICD-10-PCS codes in this DRG's assignment logic; the first 12 are shown. The manual joins this list to the one before it with "or".
| ICD-10-PCS code | Description |
|---|---|
| D020DZZ | Stereotactic Other Photon Radiosurgery of Brain |
| D020HZZ | Stereotactic Particulate Radiosurgery of Brain |
| D020JZZ | Stereotactic Gamma Beam Radiosurgery of Brain |
| D021DZZ | Stereotactic Other Photon Radiosurgery of Brain Stem |
| D021HZZ | Stereotactic Particulate Radiosurgery of Brain Stem |
| D021JZZ | Stereotactic Gamma Beam Radiosurgery of Brain Stem |
| D026DZZ | Stereotactic Other Photon Radiosurgery of Spinal Cord |
| D026HZZ | Stereotactic Particulate Radiosurgery of Spinal Cord |
| D026JZZ | Stereotactic Gamma Beam Radiosurgery of Spinal Cord |
| D027DZZ | Stereotactic Other Photon Radiosurgery of Peripheral Nerve |
| D027HZZ | Stereotactic Particulate Radiosurgery of Peripheral Nerve |
| D027JZZ | Stereotactic Gamma Beam Radiosurgery of Peripheral Nerve |
Code editor, HAC and CC/MCC exclusion notes for DRG 850
The Definitions Manual lists the diagnosis and procedure codes that lead to DRG 850; these are the ones that are also on a Medicare Code Editor list and can draw that edit.
| MCE edit | List | Codes | Examples |
|---|---|---|---|
| Edit 11 | leukemia that makes autologous marrow or stem cell transfusion non-covered | 9 | C91.00, C92.00, C92.40 |
Documentation and denial exposure
As a surgical DRG, assignment depends on a qualifying operating-room procedure being coded from the operative report; a missing or non-OR procedure code drops the stay into a medical DRG in MDC 17 with a lower weight. The inpatient claim reports that procedure in ICD-10-PCS, which NCCI does not edit; the surgeon's professional claim for the same operation carries CPT and HCPCS codes, and the NCCI pair checker for those professional codes shows whether two of them bundle. Because this family has no severity split, review risk concentrates on medical-necessity of the admission itself and on the two-midnight benchmark. Typical inpatient denial codes for this group: CARC 16 (claim lacks information needed to group the stay), CARC 50 (the admission or procedure is judged not medically necessary), CARC 97 (a service is bundled into the DRG payment).
For teams evaluating QuickIntell software
Evaluate a documentation and coding workflow for DRG 850
Explore QuickCode for qualified coder review and documentation clarification, or QuickScribe for clinician-reviewed visit documentation. Confirm inpatient scope, the supported grouper version and reviewer responsibilities during evaluation. This public reference is not a production grouper and does not determine a claim's reimbursement.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Frequently asked questions — DRG 850
What is MS-DRG 850?
MS-DRG 850 is "Acute Leukemia with Other Procedures", a surgical Medicare Severity Diagnosis-Related Group in MDC 17 (Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms). Medicare pays inpatient stays grouped here at the hospital's base rate multiplied by the DRG relative weight.
What is the FY2027 relative weight for DRG 850?
The FY2027 relative weight is 8.4113 (IPPS final rule Table 5, effective October 1, 2026). In FY2026 it was 8.6595, a change of -2.9%.
What is the Medicare base payment for MS-DRG 850?
$57,600.58 for operating costs plus $4,541.68 for capital, $62,142.26 together, at the FY2027 national rates: weight 8.4113 times the $6,848.00 operating standardized amount and the $539.95 capital rate (IPPS Tables 1A and 1D as corrected by CMS-1849-CN3). The hospital's wage index, IME, DSH, outlier and transfer adjustments change what a given stay is paid.
What is the average length of stay for DRG 850?
CMS reports a geometric mean length of stay of 15.6 days and an arithmetic mean of 23.2 days for FY2027. The geometric mean is used for transfer-payment calculations.
What documentation supports the severity level of DRG 850?
DRG 850 has no CC or MCC sibling, so secondary-diagnosis capture does not change the group or its 8.4113 weight. Review effort belongs instead on the principal diagnosis sequencing (33 qualifying principal diagnosis codes) and the 189 procedure codes that place the stay in this group, and on medical necessity of the inpatient admission itself under the two-midnight benchmark against a 15.6-day geometric mean stay, which is where denials for single-severity groups concentrate.
Which codes group to DRG 850?
The v44 Definitions Manual lists 33 principal diagnosis codes and 189 non-operating room procedures codes for this group. Examples from the principal diagnosis list, C92.51 (Acute myelomonocytic leukemia, in remission); C92.52 (Acute myelomonocytic leukemia, in relapse); and from the non-operating room procedures list, D027HZZ (Stereotactic Particulate Radiosurgery of Peripheral Nerve); D027JZZ (Stereotactic Gamma Beam Radiosurgery of Peripheral Nerve).
Is DRG 850 a post-acute transfer DRG?
No. DRG 850 is not on the FY2027 post-acute care transfer list, so the transfer per-diem policy does not apply to it.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- IPPS FY2027 Table 5 as corrected by correction notice CMS-1849-CN3Version v44 FY2027 (final rule + CN3) · effective 2026-10-01 · file CMS-1849-CN Table 5.txtSHA-256 2cc4e0b083e62e40…
- IPPS FY2026 Final Rule Table 5 (CMS-1833-F)Version v43 FY2026 · effective 2025-10-01 · file CMS-1833-F Table 5.txtSHA-256 bf8c390d14b3cd3e…
- ICD-10 MS-DRG Definitions Manual v44 (text)Version v44 · effective 2026-10-01 · file fy2027-fr-icd10-ms-drg-definitions-manual-files-v44.zipSHA-256 ae4f6c11727fe91f…
Disclaimer
This page is an operational reference compiled from the CMS IPPS FY2027 final rule (Table 5) and the v44 ICD-10 MS-DRG Definitions Manual. Relative weights are national factors; actual payment depends on each hospital's wage-adjusted base rate, add-ons, outliers and transfer adjustments. Nothing here is legal, clinical or billing advice; verify grouping against your encoder and the published CMS files.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.